ArticleAnalytical chemistry2025
Imaging of Protein Assemblies up to 231 kDa in Tissues with Nano-DESI Mass Spectrometry.
Article in Analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Fabrication of thermoplastic microfluidic probes for nanospray desorption electrospray ionization mass spectrometry.International journal of mass spectrometry · 2026Article
- Improved Protein Identification in Native Ambient Mass Spectrometry by the Integration of Proton Transfer Charge Reduction and Higher-Energy Collision Dissociation (PTCR-HCD MS3).Journal of the American Society for Mass Spectrometry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Understanding the distribution of proteins and their assemblies in tissues is a major challenge in spatial biology. Mass spectrometry imaging (MSI) with nanospray-desorption electrospray ionization (nano-DESI) has previously enabled detection, imaging, and identification of intact protein complexes directly from tissues, including protein assemblies and pathological protein-metal complexes in neurodegenerative disease. To date, nano-DESI MSI has been most effective for lower molecular weight (MW) complexes (<100 kDa), with an upper limit of 113 kDa. Here, we demonstrate nano-DESI at molecular weights up to 231 kDa, more than doubling the previous limit, by combining nano-DESI with a new mass spectrometer system architecture designed for higher MW analysis. Both mouse brain and rat kidney tissues were analyzed. Importantly, protein identification by native top-down MS was performed exclusively by use of nano-DESI. That is, complementary techniques for protein identification, such as liquid extraction surface analysis, were not necessary. Both homo- and heteromeric proteoform assemblies were identified in complex with endogenous small-molecule and metal ion cofactors. The developments lead the way to the analysis of larger oligomeric protein assemblies and protein complexes, cementing nano-DESI as a tool for structural biology, and with implications for molecular pathology and drug discovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.